Effect of Pioglitazone Therapy for Type 2 Diabetes on Vision

Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy

NCT00515632 ·Status: COMPLETED ·Phase: PHASE3

Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin

NCT00159211 ·Status: TERMINATED ·Phase: NA

Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease

NCT00479986 ·Status: COMPLETED ·Phase: PHASE4

Dapagliflozin Plus Pioglitazone in T1DM

NCT03878459 ·Status: RECRUITING ·Phase: PHASE4

Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes

NCT00991055 ·Status: UNKNOWN ·Phase: PHASE4

Epidemiologic Study Of Diabetes And Cancer Risk

NCT02958995 ·Status: COMPLETED

Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females

NCT01301456 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin

NCT06571591 ·Status: COMPLETED ·Phase: PHASE3

To Assess Safety, Tolerability, Pharmacokinetics/Pharmacodynamics and the Effect of Fasting After Single Oral Doses of AZD5658 in Type 2 Diabetes

NCT01176097 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

NCT03910361 ·Status: COMPLETED ·Phase: PHASE4

Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes

NCT05591235 ·Status: UNKNOWN ·Phase: PHASE3

Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)

NCT01588470 ·Status: COMPLETED ·Phase: PHASE4

Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy Adults

NCT01042106 ·Status: COMPLETED ·Phase: PHASE1

Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.

NCT02157298 ·Status: COMPLETED ·Phase: PHASE4

A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes

NCT01469065 ·Status: COMPLETED ·Phase: PHASE1

Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes

NCT01156597 ·Status: COMPLETED ·Phase: PHASE3

Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes

NCT00770367 ·Status: COMPLETED ·Phase: PHASE4

Effect of Dapagliflozin on Glycemic Variability

NCT02459353 ·Status: COMPLETED ·Phase: PHASE4

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

NCT00286494 ·Status: COMPLETED ·Phase: PHASE3

Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)

NCT02009488 ·Status: COMPLETED ·Phase: PHASE1

A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy

NCT06649162 ·Status: RECRUITING

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

NCT00500331 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM

NCT02581657 ·Status: COMPLETED ·Phase: PHASE2

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

NCT00086502 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

NCT00970424 ·Status: TERMINATED ·Phase: PHASE3